Drug repurposing is one of the best strategy for drug discovery. There are several examples where drug repurposing has revolutionized the drug development process, such as metformin developed for diabetes and is now employed in polycystic ovarian syndrome. Drug repurposing against breast cancer is currently a hot topic to look upon. With the continued rise in breast cancer cases, there is a dire need for new therapies that can tackle it in a better way. There is a rise of resistance to current therapies, so drug repurposing might produce some lead candidates that may be promising to treat breast cancer. We will highlight the breast cancer molecular targets, currently available drugs, problems with current therapy, and some examples that might be promising to treat it.
This manuscript suggests a generalized class of ratio-cum-product estimator in systematic sampling. The Mean Square Error (MSE) of the suggested class and mathematical conditions have been also derived to prove the efficiency of proposed estimators. The results are justified numerically.
Estrogens (estrone, estriol, and estradiol) are a class of steroidal hormones
produced by developing ovarian follicles. These hormones induce various cyclic events
in the uterine endothelium and vaginal epithelium and make the female body
competent for conception and ultimately for motherly care. While estrogen is primarily
produced by ovaries from cholesterol, the non-reproductive tissues including the brain,
liver, and heart also produce a considerable amount of it. Apart from its important role
in controlling sexual behavior and reproductive function, estrogen also functions in the
regulation of various physiological functions including reproduction, skin physiology,
cardiovascular health, skeletal homeostasis, bone integrity, electrolyte balance,
cognition, and behavior. These biological functions are regulated by diffusion through
the plasma membrane in vitro signaling through specific binding to nuclear receptors
such as estrogen receptors (ERα and ERβ) or binding to cell membrane receptors such
as GPR30 and ER-X. The signaling mechanism can be genomic (change in gene
expression) or non-genomic (activation of various signaling cascades). Disruption in
estrogen functioning has a pivotal role in the pathogenesis of many diseases such as
osteoporosis, insulin resistance, neurodegenerative disease, obesity, and endometriosis.
Also, dysregulation in the levels of estrogen has been linked to the development of
many cancers such as breast cancer, etc. This chapter aims to summarize the complete
insight of estrogen by providing a clear understanding of its synthesis, receptor
binding, signaling, regulation of physiological functions, and role in various diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.